Before this test, the specificity of the antibodies for ZKSCAN5 in IHC was determined by immunoblotting lysates from MDA-MB-231 and ZR75-1 breast cancer cells transfected with ZKSCAN5 siRNAs (Supplementary Figure S2). Here, ZKSCAN5 is linked to breast carcinoma.